Equities analysts expect American Vanguard Corp. (NYSE:AVD) to post $105.30 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for American Vanguard’s earnings, with the highest sales estimate coming in at $106.80 million and the lowest estimate coming in at $103.80 million. American Vanguard posted sales of $104.11 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 1.1%. The business is scheduled to report its next earnings results on Tuesday, May 14th.
According to Zacks, analysts expect that American Vanguard will report full year sales of $496.20 million for the current financial year, with estimates ranging from $486.30 million to $506.10 million. For the next financial year, analysts expect that the company will post sales of $526.60 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for American Vanguard.
American Vanguard (NYSE:AVD) last announced its quarterly earnings data on Monday, March 11th. The basic materials company reported $0.25 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.02. American Vanguard had a return on equity of 7.48% and a net margin of 5.33%. The firm had revenue of $131.00 million during the quarter, compared to the consensus estimate of $131.60 million.
In other news, insider John Rizzi sold 7,470 shares of the company’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $18.43, for a total transaction of $137,672.10. Following the completion of the sale, the insider now directly owns 43,072 shares in the company, valued at approximately $793,816.96. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 5.20% of the company’s stock.
A number of institutional investors have recently made changes to their positions in AVD. Walthausen & Co. LLC purchased a new position in shares of American Vanguard during the third quarter worth $11,407,000. BlackRock Inc. raised its stake in American Vanguard by 7.4% in the third quarter. BlackRock Inc. now owns 4,213,602 shares of the basic materials company’s stock valued at $75,843,000 after buying an additional 291,248 shares in the last quarter. Millennium Management LLC acquired a new stake in American Vanguard in the fourth quarter valued at $1,527,000. Vanguard Group Inc raised its stake in American Vanguard by 3.5% in the third quarter. Vanguard Group Inc now owns 2,737,677 shares of the basic materials company’s stock valued at $49,278,000 after buying an additional 93,491 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in American Vanguard by 3.5% in the third quarter. Vanguard Group Inc. now owns 2,737,677 shares of the basic materials company’s stock valued at $49,278,000 after buying an additional 93,491 shares in the last quarter. 77.28% of the stock is owned by hedge funds and other institutional investors.
AVD stock traded up $0.01 during midday trading on Friday, hitting $16.97. The company had a trading volume of 3,544 shares, compared to its average volume of 99,644. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.03 and a current ratio of 2.13. American Vanguard has a 52 week low of $13.98 and a 52 week high of $24.00. The company has a market capitalization of $503.55 million, a P/E ratio of 20.95 and a beta of 1.27.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 10th. Stockholders of record on Wednesday, March 27th will be issued a dividend of $0.02 per share. The ex-dividend date of this dividend is Tuesday, March 26th. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.47%. American Vanguard’s payout ratio is 9.88%.
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Article: Outstanding Shares
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.